Bay Area based Universal Brain has developed a wearable dry EEG (now 501(k) cleared by FDA) that aims to measure task based biomarkers of brain function for psychiatry
- 20 minutes ago
- 1 min read
Founder and CEO Kazu Okuda describes the effort to make this technology a reality. He says they have already published evidence that the device can measure the onset of and predict the remission of depression, and the ultimate goal is to get it to a place one day where it can help predict response to therapies.
.png){kind=logo}